In their paper the authors describe distinct transcriptomic changes associated to treatment response in core bone marrow biopsies from patients with acute myeloid leukaemia. This finding raises the possibility that stratifying patients for treatment according to their transcriptomic profiles could improve patients' response and prognosis. Commentary on: Treaba et al. Transcriptomics of AML core bone marrow biopsies reveals distinct therapy response-specific osteo-mesenchymal profiles. Br J Haematol 2023;200:740-754.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/bjh.18579 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!